Achilles Therapeutics (ACHL) has released an update.
Achilles Therapeutics has announced changes in its leadership, with Karl Peggs stepping down as Chief Medical Officer to dedicate more time to his roles at UCLH and NIHR UCLH BRC, but he will continue to advise the company. Matilde Saggese, previously Vice President and Medical Director, has been appointed as the Interim CMO.
For further insights into ACHL stock, check out TipRanks’ Stock Analysis page.
